Eades_2022_Curr.Drug.Metab__

Reference

Title : Covalent CES2 Inhibitors Protect against Reduced Formation of Intestinal Organoids by the Anticancer Drug Irinotecan - Eades_2022_Curr.Drug.Metab__
Author(s) : Eades W , Liu W , Shen Y , Shi Z , Yan B
Ref : Curr Drug Metab , : , 2022
Abstract : Eades_2022_Curr.Drug.Metab__
ESTHER : Eades_2022_Curr.Drug.Metab__
PubMedSearch : Eades_2022_Curr.Drug.Metab__
PubMedID: 36515038

Related information

Citations formats

Eades W, Liu W, Shen Y, Shi Z, Yan B (2022)
Covalent CES2 Inhibitors Protect against Reduced Formation of Intestinal Organoids by the Anticancer Drug Irinotecan
Curr Drug Metab :

Eades W, Liu W, Shen Y, Shi Z, Yan B (2022)
Curr Drug Metab :